
Stay Updated with the Latest YieldMax Ultra Option Income Strategy ETF ULTY News in Real Time
Find ULTY news now at Meyka AI. Stay informed with the latest YieldMax Ultra Option Income Strategy ETF stocks updates, including price news, market analysis, and expert insights.

Oracle Cuts 21,000 Jobs as Workforce Falls to 141,000, AI-Driven Restructuring Trims 13% of Staff
Oracle’s workforce dropped to 141,000 employees in fiscal 2026 after the company reduced its headcount by about 21,000 workers, a decline of roughly 13%. The move comes as Oracle accelerates its investment in artificial intelligence, cloud services, and large-scale data centers. Announced in June 2026, the restructuring reflects a growing trend across the tech industry,…

AI Startup Baseten Reaches $13 Billion Valuation After Raising $1.5 Billion in New Funding Round
AI infrastructure startup Baseten has made headlines after raising $1.5 billion in a new funding round that boosted its valuation to $13 billion in June 2026. The deal highlights the growing investor focus on the technology that powers AI applications behind the scenes. As businesses rush to deploy AI tools at scale, companies that help…

Vedanta Ltd (NSE: VEDL) Falls 6.67% to ₹285.45 as Promoter Twin Star May Sell ₹2,150 Crore Stake
Vedanta shares took a sharp hit on June 23, 2026, tumbling 6.67% to ₹285.45 on the NSE in early trade. Promoter entity Twin Star Holdings, which held a 40.02% stake in Vedanta as of March 2026, initiated a block deal to offload up to 6.5 crore shares at a floor price of ₹291 per share,…

Voltas Ltd (NSE: VOLTAS) Falls 1.87% to ₹1,328.70 as Company Sells 1 Million AC Units in Q1 FY27
Voltas achieved a major milestone in the first quarter of FY27, selling more than 1 million air conditioners in record time. The announcement came in June 2026, highlighting strong demand for cooling products across India despite a competitive market. Yet, the company’s share price slipped 1.87% to ₹1,328.70, raising questions among investors. Why did the…

Lloyds Banking Group PLC (LON: LLOY) Gains 0.048% as Lloyds Confirms 233 Branch Closures Across the UK
Lloyds Banking Group PLC (LON: LLOY) edged up 0.048% on June 23, 2026, trading at approximately 105.10p. The gain comes on the same day the group formally confirmed 233 branch closures in 2026, with another 12 sites set to follow in early 2027. The banking giant has now closed nearly 1,600 branches across the UK…

Kunal Shah’s Biggest Win Yet? Meta’s $900 Million Move Raises New Questions
Kunal Shah has entered a new phase of his career after Meta announced a $900 million investment in CRED and appointed him as the new global leader of WhatsApp. The move is one of the biggest leadership changes in the technology sector this year. It not only strengthens Meta’s presence in India but also raises…

Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…

SpaceX Shares Fall More Than 5% Premarket, Extending Post-IPO Pullback After Record Rally
SpaceX shares came under pressure on June 22, 2026, falling more than 5% in premarket trading after an extraordinary post-IPO rally that captured Wall Street’s attention. The stock had surged to record highs in the days following its market debut, pushing the company’s valuation to unprecedented levels. Now, investors are weighing whether the recent decline…

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…